Short description
Myrcludex B is a drug against hepatitis B and hepatitis D.

Detailed description

The medication developed by DZIF scientists prevents hepatitis B viruses and hepatitis D viruses from entering liver cells. Co-infection of hepatitis B and hepatitis D presents the most serious form of viral hepatitis and was untreatable until then. Myrcludex B is a substance well tolerated by humans and it prevents viral reproduction.